KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onto Innovation (ONTO) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Onto Innovation (ONTO) over the last 15 years, with Q3 2025 value amounting to $1.4 million.

  • Onto Innovation's Capital Expenditures fell 8286.74% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.0 million, marking a year-over-year decrease of 581.71%. This contributed to the annual value of $31.9 million for FY2024, which is 4133.26% up from last year.
  • Per Onto Innovation's latest filing, its Capital Expenditures stood at $1.4 million for Q3 2025, which was down 8286.74% from $13.8 million recorded in Q2 2025.
  • Onto Innovation's Capital Expenditures' 5-year high stood at $13.8 million during Q2 2025, with a 5-year trough of $1.4 million in Q3 2025.
  • For the 5-year period, Onto Innovation's Capital Expenditures averaged around $6.3 million, with its median value being $5.8 million (2024).
  • In the last 5 years, Onto Innovation's Capital Expenditures soared by 28866.6% in 2021 and then plummeted by 8286.74% in 2025.
  • Onto Innovation's Capital Expenditures (Quarter) stood at $3.9 million in 2021, then soared by 122.43% to $8.6 million in 2022, then crashed by 71.42% to $2.5 million in 2023, then soared by 87.82% to $4.6 million in 2024, then crashed by 70.19% to $1.4 million in 2025.
  • Its last three reported values are $1.4 million in Q3 2025, $13.8 million for Q2 2025, and $8.2 million during Q1 2025.